Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Elkins David V
Relationship:   Director
City:   Franklin Lakes
State:   NJ
   
Insider Summary:
  
   
Companies Owned :   4    
Direct Shares   196,756    

Indirect Shares

   216      
Direct Value   $8,792,312    

Indirect Value

   $9,657      
Total Shares   196,972      
Total Value   $8,801,969      


Bristol-Myers Squibb Co $8,717,019 Tapestry Inc $75,293 Bristol-Myers Squibb Co $8,717,019 Tapestry Inc $75,293
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    2    

     Stock price went up :
    0   
    1    
     Stock price went down :
    0   
    1    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
 5.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Becton Dickinson & Co BDX Executive VP and CFO 2012-11-09 0 0    Premium*  
            Celgene Corp CELG 2019-11-20 0 2019-11-20 0    Premium*  
            Bristol-Myers Squibb Co BMY EVP, Chief Financial O... 2024-03-10 194,968 2024-03-10 216    Premium*  
            Tapestry Inc TPR Director 2024-02-29 1,788 2024-02-29 0    Premium*  
* Premium Members only  

Records found :    52         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 3
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
BDX Becton Dickinson & Co Executive VP and CFOOfficer   •       –      –    2008-12-01 3 IO $0.00 $0 D/D 0 5,285 -
BMY Bristol-Myers Squibb Co EVP, Chief Financial Officer   •       –      –    2021-03-10 4 A $0.00 $0 D/D 150 91,361 0 -
CELG Celgene Corp EVP, CHIEF FINANCIAL OFFICER   •       –      –    2019-11-20 4 D $0.00 $0 I/I (195) 0 0 -
BMY Bristol-Myers Squibb Co EVP, Chief Financial Officer   •       –      –    2019-11-20 4 A $0.00 $0 I/I 195 195 0 -
TPR Tapestry Inc Director   •       •      –    2024-02-29 4 A $47.53 $84,984 D/D 1,788 1,788 0 -
BMY Bristol-Myers Squibb Co EVP, Chief Financial Officer   •       –      –    2022-03-10 4 A $0.00 $0 D/D 1,962 135,035 0 -
BDX Becton Dickinson & Co Executive VP and CFO   •       –      –    2011-12-01 4 D $0.00 $0 D/D (2,039) 9,115 0 -
BDX Becton Dickinson & Co Executive VP and CFO   •       –      –    2012-11-08 4 S $75.17 $270,762 D/D (3,602) 5,513 0 -
BMY Bristol-Myers Squibb Co EVP, Chief Financial Officer   •       –      –    2023-12-02 4 D $50.10 $186,873 D/D (3,730) 168,612 0 -
BMY Bristol-Myers Squibb Co EVP, Chief Financial Officer   •       –      –    2021-03-10 4 D $60.93 $263,766 D/D (4,329) 87,032 0 -
BMY Bristol-Myers Squibb Co EVP, Chief Financial Officer   •       –      –    2021-12-02 4 D $55.41 $249,234 D/D (4,498) 84,302 0 -
BMY Bristol-Myers Squibb Co EVP, Chief Financial Officer   •       –      –    2022-12-02 4 D $81.13 $364,923 D/D (4,498) 124,080 0 -
BMY Bristol-Myers Squibb Co EVP, Chief Financial Officer   •       –      –    2020-12-02 4 D $62.18 $316,310 D/D (5,087) 58,487 0 -
BDX Becton Dickinson & Co Executive VP and CFO   •       –      –    2012-11-09 4 D $0.00 $0 D/D (5,513) 0 0 -
BMY Bristol-Myers Squibb Co EVP, Chief Financial Officer   •       –      –    2019-12-31 4 D $64.19 $391,174 D/D (6,094) 20,187 0 -
BMY Bristol-Myers Squibb Co EVP, Chief Financial Officer   •       –      –    2021-03-10 4 OE $0.00 $0 D/D 8,025 91,211 0 -
BMY Bristol-Myers Squibb Co EVP, Chief Financial Officer   •       –      –    2021-03-01 4 D $61.63 $528,354 D/D (8,573) 83,186 0 -
BMY Bristol-Myers Squibb Co EVP, Chief Financial Officer   •       –      –    2020-12-02 4 OE $0.00 $0 D/D 8,792 63,574 0 -
BMY Bristol-Myers Squibb Co EVP, Chief Financial Officer   •       –      –    2021-12-02 4 OE $0.00 $0 D/D 8,792 88,800 0 -
BMY Bristol-Myers Squibb Co EVP, Chief Financial Officer   •       –      –    2022-12-02 4 OE $0.00 $0 D/D 8,792 128,578 0 -
BMY Bristol-Myers Squibb Co EVP, Chief Financial Officer   •       –      –    2023-12-02 4 OE $0.00 $0 D/D 8,792 172,342 0 -
BMY Bristol-Myers Squibb Co EVP, Chief Financial Officer   •       –      –    2023-03-10 4 A $0.00 $0 D/D 8,930 191,187 0 -
BMY Bristol-Myers Squibb Co EVP, Chief Financial Officer   •       –      –    2022-03-10 4 D $68.42 $630,969 D/D (9,222) 130,460 0 -
BMY Bristol-Myers Squibb Co EVP, Chief Financial Officer   •       –      –    2022-03-01 4 D $68.63 $712,448 D/D (10,381) 121,653 0 -
BMY Bristol-Myers Squibb Co EVP, Chief Financial Officer   •       –      –    2020-03-01 4 D $59.06 $618,358 D/D (10,470) 34,296 0 -
  52  Records found
  1  2   3      
  Page 1 of 3  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us